Rehman, H., Silk, A. W., Kane, M. P., & Kaufman, H. L. (2016). Into the clinic: Talimogene laherparepvec (T-VEC), a first-in-class intratumoral oncolytic viral therapy. J Immunother Cancer.
Citación estilo ChicagoRehman, Hasan, Ann W. Silk, Michael P. Kane, y Howard L. Kaufman. "Into the Clinic: Talimogene Laherparepvec (T-VEC), a First-in-class Intratumoral Oncolytic Viral Therapy." J Immunother Cancer 2016.
Cita MLARehman, Hasan, Ann W. Silk, Michael P. Kane, y Howard L. Kaufman. "Into the Clinic: Talimogene Laherparepvec (T-VEC), a First-in-class Intratumoral Oncolytic Viral Therapy." J Immunother Cancer 2016.
Precaución: Estas citas no son 100% exactas.